FGFR1 and glioblastoma: attempted to target FGFR1 by AON, which significantly inhibited FGFR1 expression and reduced GBM cell growth.[159] Attempts are also being made to develop multiple RTKs‐targeted genetic therapeutics for GBM treatment.